In some cases. We would only recommend it in men with secondary hypogonadism, as men with primary hypogonadism will not have any benefit from these medications because their testicles have stopped wor... See Full Answer
The best case & results we've seen for it's use has been for men who have higher base Testosterone levels, aka relative hypogonadism TRT candidates. Since it is another medication which boosts your pr... See Full Answer
For you the answer would probably: Both are just fine. It more depends on your goals & what Sx you're feeling. First, it's good to find a provider to is chill with previous UGL use & can advise on wha... See Full Answer
At AlphaMD, we're here to help. Feel free to ask us any question you would like about TRT, medical weightloss, ED, or other topics related to men's health. Or take a moment to browse through our past questions.
Purpose: We evaluated the relative prevalence of secondary polycythemia in hypogonadal men treated with clomiphene citrate or testosterone replacement therapy.
Materials and methods: In this retrospective, multi-institutional study, we included 188 men who received clomiphene citrate and 175 who received testosterone replacement therapy with symptomatic hypogonadism. The overall prevalence and ORs of secondary polycythemia for clomiphene citrate treatment vs testosterone replacement were primarily measured, as were baseline characteristics. Subset analysis included polycythemia rates for different types of testosterone replacement therapy.
Results: Overall, men on testosterone replacement therapy were older than clomiphene citrate treated men (age 51.5 vs 38 years). Men on testosterone replacement had longer treatment duration than clomiphene citrate treated men (19.6 vs 9.2 months). For testosterone replacement therapy and clomiphene citrate the mean change in hematocrit was 3.0% and 0.6%, and the mean change in serum testosterone was 333.1 and 367.6 ng/dl, respectively. The prevalence of polycythemia in men on testosterone replacement was 11.2% vs 1.7% in men on clomiphene citrate (p = 0.0003). This significance remained on logistic regression after correcting for age, site, smoking history and pretreatment hematocrit.
At AlphaMD, we're here to help. Feel free to ask us any question you would like about TRT, medical weightloss, ED, or other topics related to men's health. Or take a moment to browse through our past questions.
Conclusions: The prevalence of polycythemia in men treated with clomiphene citrate was markedly lower than that in men on testosterone replacement therapy. The improvement in absolute serum testosterone levels was similar to that in men on testosterone replacement. There is no significant risk of polycythemia in men treated with clomiphene citrate for hypogonadism.
In some cases. We would only recommend it in men with secondary hypogonadism, as men with primary hypogonadism will not have any benefit from these medications because their testicles have stopped wor... See Full Answer
The best case & results we've seen for it's use has been for men who have higher base Testosterone levels, aka relative hypogonadism TRT candidates. Since it is another medication which boosts your pr... See Full Answer
For you the answer would probably: Both are just fine. It more depends on your goals & what Sx you're feeling. First, it's good to find a provider to is chill with previous UGL use & can advise on wha... See Full Answer
Enter your email address now to receive $30 off your first month’s cost, other discounts, and additional information about TRT.
This website is a repository of publicly available information and is not intended to form a physician-patient relationship with any individual. The content of this website is for informational purposes only. The information presented on this website is not intended to take the place of your personal physician's advice and is not intended to diagnose, treat, cure, or prevent any disease. Discuss this information with your own physician or healthcare provider to determine what is right for you. All information is intended for your general knowledge only and is not a substitute for medical advice or treatment for specific medical conditions. The information contained herein is presented in summary form only and intended to provide broad consumer understanding and knowledge. The information should not be considered complete and should not be used in place of a visit, phone or telemedicine call, consultation or advice of your physician or other healthcare provider. Only a qualified physician in your state can determine if you qualify for and should undertake treatment.